Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring

Brief summary (registry, in English)

This study will evaluate whether Continuous Glucose Monitoring (CGM) can identify previously unrecognized diabetes and clinically significant hyperglycemia in adults with end-stage kidney disease (ESKD) receiving hemodialysis who have no known history of diabetes. Participants will wear a CGM sensor for up to 15 days and undergo standard diabetes assessments, including fasting plasma glucose and hemoglobin. The primary objectives are to: * Determine the prevalence of previously undiagnosed diabetes among dialysis patients using OGTT criteria. * Compare CGM glucose patterns between participants with and without diabetes as determined by OGTT results.

What you commit to

• Study type: Observational
• Planned participants: 180
• From Dec 2026 to the primary completion date, Nov 2027
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.